Semi-Annual Statement Of Cash Flows

OncoTherapy Science, Inc. - Filing #7725694

Concept 2017-04-01 to
2018-03-31
As at
2018-03-31
2017-04-01 to
2018-03-31
2016-04-01 to
2017-03-31
2016-04-01 to
2017-03-31
As at
2017-03-31
As at
2016-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-2,919,262,000 JPY
-2,626,813,000 JPY
-2,991,427,000 JPY
-2,997,571,000 JPY
Depreciation
148,657,000 JPY
89,653,000 JPY
Decrease (increase) in trade receivables
1,347,000 JPY
-1,790,000 JPY
Decrease (increase) in inventories
-1,548,000 JPY
2,767,000 JPY
Other, net
-45,745,000 JPY
-76,797,000 JPY
Subtotal
-3,032,596,000 JPY
-2,985,229,000 JPY
Income taxes paid
-4,536,000 JPY
-4,391,000 JPY
Net cash provided by (used in) operating activities
-3,035,947,000 JPY
-2,988,040,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-408,888,000 JPY
-10,754,000 JPY
Other, net
-11,057,000 JPY
-1,203,000 JPY
Net cash provided by (used in) investing activities
-446,421,000 JPY
-11,958,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
640,000 JPY
2,330,000 JPY
Net cash provided by (used in) financing activities
150,640,000 JPY
2,330,000 JPY
Effect of exchange rate change on cash and cash equivalents
-995,000 JPY
337,000 JPY
Net increase (decrease) in cash and cash equivalents
-3,332,724,000 JPY
-2,997,331,000 JPY
Cash and cash equivalents
6,740,238,000 JPY
10,072,962,000 JPY
13,070,294,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.